Abstract
In the present dose and schedule, the authors found hexamethylmelamine to be ineffective in the management of metastatic breast cancer already refractory to standard chemotherapy and hormonal therapeutic approaches in 19 cases.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 173-175 |
| Number of pages | 3 |
| Journal | Cancer Treatment Reports |
| Volume | 62 |
| Issue number | 1 |
| State | Published - Jan 1 1978 |
ASJC Scopus subject areas
- Oncology
- Cancer Research
Fingerprint Dive into the research topics of 'Phase II study of hexamethylmelamine in women with advanced breast cancer refractory to standard cytotoxic therapy'. Together they form a unique fingerprint.
Cite this
Denefrio, J. M., & Vogel, C. L. (1978). Phase II study of hexamethylmelamine in women with advanced breast cancer refractory to standard cytotoxic therapy. Cancer Treatment Reports, 62(1), 173-175.